Results 61 to 70 of about 1,282 (161)
British Journal of Haematology, Volume 208, Issue 1, Page 250-258, January 2026.The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune +20 more
wiley +1 more source
European Journal of Neurology, Volume 33, Issue 1, January 2026.Neurological infections caused by Borrelia burgdorferi sensu lato and Borrelia miyamotoi are increasingly reported in patients receiving anti‐CD20 therapies and should be considered in cases presenting with neurological symptoms and cerebrospinal fluid pleocytosis.
Emilie Cardot‐Martin +7 more
wiley +1 more source
Pediatric Transplantation, Volume 30, Issue 1, January 2026.AB0‐incompatible kidney transplantation in children can be performed with excellent results. Midterm outcome of AB0 incompatible KTx was not inferior to that of AB0 compatible KTx. Graft survival and graft function were comparably good in both groups. There was no increase in infectious complications or malignancies with AB0i KTx.
Christina Taylan +4 more
wiley +1 more source
Intestinal and Multivisceral Transplantation: Where We Stand Today
Pediatric Transplantation, Volume 30, Issue 1, January 2026.ABSTRACT Intestinal and multivisceral transplantation has evolved from an experimental to a life‐saving procedure for children and adults with complications of gut failure (GF). Suboptimal long‐term outcomes of transplant elicit recent advances in surgical and medical gut rehabilitation along with the introduction of glucagon‐like peptide‐2 (GLP‐2 ...
Mohamed Maklad +5 more
wiley +1 more source
Transplant Infectious Disease, Volume 28, Issue 1, January/February 2026.A sudden increase in EBV DNAemia appears to be a better predictor of PTLD and EBV end‐organ disease than persistent and stable levels of EBV DNAemia. Most HCT recipients with EBV DNAemia did not require rituximab, and immunosuppression reduction was sufficient to control most episodes of EBV reactivation.
Anna Beatriz Coelho de Souza +12 more
wiley +1 more source
Case Reports in Hematology, 2013 Second cancers and particularly postransplant lymphoproliferative disorders (PTLDs) are extremely rare in patients undergoing autologous peripheral blood stem cell transplantation (auto-SCT).
Giuseppe Mele +6 more
doaj +1 more source
Case Reports in Hematology, 2017 Posttransplant lymphoproliferative disorders (PTLDs) are a diverse group of lymphoid or plasmacytic proliferations frequently driven by Epstein-Barr virus (EBV). EBV-negative PTLDs appear to represent a distinct entity.
Agata M. Bogusz
doaj +1 more source
A case of posttransplant lymphoproliferative disorder
Journal of Marine Medical Society, 2017 Posttransplant lymphoproliferative disorders (PTLDs) are life-threatening complications of solid-organ and bone marrow transplantations leading to a high mortality. PTLD represents a heterogeneous group of lymphoproliferative diseases.
G S Chowdhary +2 more
doaj +1 more source
Classical Hodgkin lymphoma type PTLD [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2018 Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of transplantation, which represent a heterogeneous group of lymphoproliferative diseases and show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas.
openaire +2 more sources
Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
Leukemia Research Reports, 2018 Posttransplant lymphoproliferative disorders (PTLDs) of T-cell orgin are rare biologically heterogeneous diseases of mature lymphoid cells manifesting in immunosuppressed patients.
Thanh-Phuong Afiat +5 more
doaj +1 more source